Literature DB >> 19572575

Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majuscula.

Marcelino Gutiérrez1, Eric H Andrianasolo, Won Kyo Shin, Douglas E Goeger, Alexandre Yokochi, Jörg Schemies, Manfred Jung, Dennis France, Susan Cornell-Kennon, Eun Lee, William H Gerwick.   

Abstract

Tanikolide seco-acid 2 and tanikolide dimer 3, the latter a novel and selective SIRT2 inhibitor, were isolated from the Madagascar marine cyanobacterium Lyngbya majuscula. The structure of 2, isolated as the pure R enantiomer, was elucidated by X-ray experiment in conjunction with NMR and optical rotation data, whereas the depside molecular structure of 3 was initially thought to be a meso compound as established by NMR, MS, and chiral HPLC analyses. Subsequent total synthesis of the three tanikolide dimer stereoisomers 4, 5, and ent-5, followed by chiral GC-MS comparisons with the natural product, showed it to be exclusively the R,R-isomer 5. Tanikolide dimer 3 (= 5) inhibited SIRT2 with an IC(50) = 176 nM in one assay format and 2.4 microM in another. Stereochemical determination of symmetrical dimers such as compound 3 pose intriguing and subtle questions in structure elucidation and, as shown in the current work, are perhaps best answered in conjunction with total synthesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572575      PMCID: PMC2736347          DOI: 10.1021/jo900578j

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  27 in total

1.  Mechanism and activity of ruthenium olefin metathesis catalysts.

Authors:  M S Sanford; J A Love; R H Grubbs
Journal:  J Am Chem Soc       Date:  2001-07-11       Impact factor: 15.419

2.  Structure of a Sir2 enzyme bound to an acetylated p53 peptide.

Authors:  Jose L Avalos; Ivana Celic; Shabazz Muhammad; Michael S Cosgrove; Jef D Boeke; Cynthia Wolberger
Journal:  Mol Cell       Date:  2002-09       Impact factor: 17.970

3.  Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Authors:  Sylvia C Dryden; Fatimah A Nahhas; James E Nowak; Anton-Scott Goustin; Michael A Tainsky
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

4.  The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

Authors:  Brian J North; Brett L Marshall; Margie T Borra; John M Denu; Eric Verdin
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

5.  Negative control of p53 by Sir2alpha promotes cell survival under stress.

Authors:  J Luo; A Y Nikolaev; S Imai; D Chen; F Su; A Shiloh; L Guarente; W Gu
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

6.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

7.  Human Sir2 and the 'silencing' of p53 activity.

Authors:  Jeffrey Smith
Journal:  Trends Cell Biol       Date:  2002-09       Impact factor: 20.808

8.  Thiobarbiturates as sirtuin inhibitors: virtual screening, free-energy calculations, and biological testing.

Authors:  Urszula Uciechowska; Jörg Schemies; Robert C Neugebauer; Elisabeth-Maria Huda; Martin L Schmitt; Rene Meier; Eric Verdin; Manfred Jung; Wolfgang Sippl
Journal:  ChemMedChem       Date:  2008-12       Impact factor: 3.466

9.  Vanadium-catalyzed selenide oxidation with in situ[2,3] sigmatropic rearrangement (SOS reaction): scope and asymmetric applications.

Authors:  T Campbell Bourland; Rich G Carter; Alexandre F T Yokochi
Journal:  Org Biomol Chem       Date:  2004-03-31       Impact factor: 3.876

10.  Total synthesis of (+)-tanikolide via oxidative lactonization.

Authors:  Jennifer M Schomaker; Babak Borhan
Journal:  Org Biomol Chem       Date:  2004-01-27       Impact factor: 3.876

View more
  19 in total

Review 1.  Biologically active secondary metabolites from marine cyanobacteria.

Authors:  Joshawna K Nunnery; Emily Mevers; William H Gerwick
Journal:  Curr Opin Biotechnol       Date:  2010-10-26       Impact factor: 9.740

Review 2.  Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Authors:  Lilibeth A Salvador-Reyes; Hendrik Luesch
Journal:  Nat Prod Rep       Date:  2015-03       Impact factor: 13.423

3.  Creation of an HDAC-based yeast screening method for evaluation of marine-derived actinomycetes: discovery of streptosetin A.

Authors:  Taro Amagata; Jing Xiao; Yi-Pei Chen; Nicholas Holsopple; Allen G Oliver; Trevor Gokey; Anton B Guliaev; Katsuhiko Minoura
Journal:  J Nat Prod       Date:  2012-11-20       Impact factor: 4.050

Review 4.  Sirtuin activators and inhibitors: Promises, achievements, and challenges.

Authors:  Han Dai; David A Sinclair; James L Ellis; Clemens Steegborn
Journal:  Pharmacol Ther       Date:  2018-03-22       Impact factor: 12.310

Review 5.  Sirtuin modulators.

Authors:  Sumit S Mahajan; Vid Leko; Julian A Simon; Antonio Bedalov
Journal:  Handb Exp Pharmacol       Date:  2011

6.  Malyngolide dimer, a bioactive symmetric cyclodepside from the panamanian marine cyanobacterium Lyngbya majuscula.

Authors:  Marcelino Gutiérrez; Kevin Tidgewell; Todd L Capson; Niclas Engene; Alejandro Almanza; Jörg Schemies; Manfred Jung; William H Gerwick
Journal:  J Nat Prod       Date:  2010-04-23       Impact factor: 4.050

Review 7.  Sirtuin inhibitors as anticancer agents.

Authors:  Jing Hu; Hui Jing; Hening Lin
Journal:  Future Med Chem       Date:  2014-05       Impact factor: 3.808

8.  Discovery, Total Synthesis and Key Structural Elements for the Immunosuppressive Activity of Cocosolide, a Symmetrical Glycosylated Macrolide Dimer from Marine Cyanobacteria.

Authors:  Sarath P Gunasekera; Yang Li; Ranjala Ratnayake; Danmeng Luo; Jeannette Lo; Joseph H Reibenspies; Zhengshuang Xu; Michael J Clare-Salzler; Tao Ye; Valerie J Paul; Hendrik Luesch
Journal:  Chemistry       Date:  2016-05-03       Impact factor: 5.236

Review 9.  The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology.

Authors:  Zhongping Lu; Iain Scott; Bradley R Webster; Michael N Sack
Journal:  Circ Res       Date:  2009-10-23       Impact factor: 17.367

Review 10.  Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy.

Authors:  Yuki Maemoto; Yuki Shimizu; Ryu Katoh; Akihiro Ito
Journal:  J Antibiot (Tokyo)       Date:  2021-08-23       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.